Sona Nanotech Inc. (CSE:SONA)

Canada flag Canada · Delayed Price · Currency is CAD
0.350
-0.020 (-5.41%)
Feb 21, 2025, 3:41 PM EST
18.64%
Market Cap 39.10M
Revenue (ttm) n/a
Net Income (ttm) -3.02M
Shares Out 111.72M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 156,200
Average Volume 53,718
Open 0.375
Previous Close 0.370
Day's Range 0.350 - 0.390
52-Week Range 0.235 - 0.560
Beta -1.64
RSI 68.81
Earnings Date Feb 27, 2025

About Sona Nanotech

Sona Nanotech Inc. operates as a nanotechnology life sciences company. It develops targeted hyperthermia therapy for cancer treatment; and nanomedical therapy for the treatment of colorectal cancer. The company also develops gold nanoparticle products; lateral flow assay rapid tests; bovine TB tests; and concussion screening tests. Sona Nanotech Inc. was founded in 2013 and is based in Halifax, Canada. [Read more]

Sector Healthcare
Founded 2013
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol SONA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.